AusCann strengthens strategic partnerships during June Quarter
Highlights
-
Commencement of Mr Ido Kanyon as new CEO of AusCann
-
First commercial shipment of medical cannabis concentrate from MediPharm Labs completed, representing first ever bulk international shipment of active pharmaceutical ingredient medical cannabis concentrate from Canada to Australia
-
New supply agreement with TasAlk, in line with AusCann’s strategy to de-risk supply chain and secure high-quality pharmaceutical suppliers across the product value chain
For further information please download the attached PDF:
Download this document
